Venus Medtech (Hangzhou) Inc. Stock price
Equities
2500
CNE100003PJ8
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.62 HKD | -0.71% | -.--% | -.--% |
Sales 2023 * | 564M 78.04M 611M | Sales 2024 * | 812M 112M 879M | Capitalization | 2.26B 312M 2.44B |
---|---|---|---|---|---|
Net income 2023 * | -575M -79.55M -622M | Net income 2024 * | -251M -34.73M -272M | EV / Sales 2023 * | 3.28 x |
Net cash position 2023 * | 410M 56.67M 443M | Net Debt 2024 * | 125M 17.31M 135M | EV / Sales 2024 * | 2.93 x |
P/E ratio 2023 * |
-3.96
x | P/E ratio 2024 * |
-9.14
x | Employees | 1,006 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 73.87% |
1 day | -0.71% | ||
6 months | +15.40% |
Managers | Title | Age | Since |
---|---|---|---|
Hou-Sen Lim
CEO | Chief Executive Officer | 50 | 16-11-30 |
Fei Wang
DFI | Director of Finance/CFO | 47 | 23-01-03 |
Meirong Liu
BRD | Director/Board Member | 47 | 17-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hou-Sen Lim
CEO | Chief Executive Officer | 50 | 16-11-30 |
Ting Yuk Wu
CHM | Chairman | 69 | 18-11-25 |
Wei Wang
BRD | Director/Board Member | 41 | 18-11-25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 115 M€ | +4.54% | - | |
0.00% | 4 M€ | -4.41% | - | |
0.00% | 36 M€ | +4.74% | - |
Date | Price | Change | Volume |
---|
Delayed Quote Hong Kong S.E., November 22, 2023 at 03:08 am EST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-.--% | 315M | |
+19.79% | 136B | |
-6.68% | 11.49B | |
+15.53% | 10.12B | |
+4.95% | 6.47B | |
+16.61% | 4.58B | |
+10.72% | 3.51B | |
+11.50% | 3.43B | |
-11.59% | 2.08B | |
-10.32% | 2B |